Patriot Financial Group Insurance Agency LLC Purchases 8,861 Shares of SPDR S&P Biotech ETF $XBI

Patriot Financial Group Insurance Agency LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 118.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,322 shares of the exchange traded fund’s stock after buying an additional 8,861 shares during the period. Patriot Financial Group Insurance Agency LLC’s holdings in SPDR S&P Biotech ETF were worth $2,085,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. AQR Capital Management LLC boosted its position in SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of SPDR S&P Biotech ETF by 102.3% in the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares during the period. The Manufacturers Life Insurance Company bought a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth approximately $260,000. Ameriprise Financial Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares during the last quarter. Finally, EP Wealth Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after buying an additional 193 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $155.38 on Monday. SPDR S&P Biotech ETF has a 12-month low of $82.04 and a 12-month high of $155.93. The firm has a market capitalization of $9.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The firm has a 50 day moving average of $135.24 and a 200 day moving average of $128.73.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.